Mine & Arao Wealth Creation & Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-45
Closed -$2.44K – 107
2024
Q1
$2.44K Hold
45
– – ﹤0.01% 271
2023
Q4
$2.31K Hold
45
– – ﹤0.01% 282
2023
Q3
$2.61K Hold
45
– – ﹤0.01% 276
2023
Q2
$2.88K Sell
45
-129
-74% -$8.65K ﹤0.01% 286
2023
Q1
$12.1K Hold
174
– – 0.01% 210
2022
Q4
$12.5K Hold
174
– – 0.01% 204
2022
Q3
$12K Buy
174
+129
+287% +$9.36K 0.01% 212
2022
Q2
$3K Hold
45
– – ﹤0.01% 286
2022
Q1
$3K Hold
45
– – ﹤0.01% 284
2021
Q4
$3K Hold
45
– – ﹤0.01% 284
2021
Q3
$3K Hold
45
– – ﹤0.01% 258
2021
Q2
$3K Hold
45
– – ﹤0.01% 253
2021
Q1
$3K Hold
45
– – ﹤0.01% 243
2020
Q4
$3K Hold
45
– – ﹤0.01% 245
2020
Q3
$3K Hold
45
– – ﹤0.01% 239
2020
Q2
$3K Hold
45
– – ﹤0.01% 217
2020
Q1
$3K Hold
45
– – ﹤0.01% 212
2019
Q4
$3K Buy
+45
New +$2.58K ﹤0.01% 220

Other funds holding BMY

Mine & Arao Wealth Creation & Management's BMY Position: Q2 2024 in Review

Mine & Arao Wealth Creation & Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 45 shares — an estimated $2.44K sold.

Mine & Arao Wealth Creation & Management first reported a position in BMY in Q4 2019 and held it in 18 quarters. The position peaked at $12.5K in Q4 2022. 2,154 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Mine & Arao Wealth Creation & Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 45 Bristol-Myers Squibb shares in Q2 2024, an estimated $2.44K.
  • Mine & Arao Wealth Creation & Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 18 quarters.
  • Mine & Arao Wealth Creation & Management's Bristol-Myers Squibb position peaked at $12.5K in Q4 2022.
  • 2,154 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2024, filed 6 Aug 2024.